JBCHEPHARM vs ORTINGLOBE: Stock Comparison

JB Chemicals & Pharmaceuticals Limited vs ORTIN GLOBAL LIMITED

Live data: 16 July 2026, 4:08 PM IST • Source: NSE and company filings

JB Chemicals & Pharmaceuticals Limited is the larger company by market capitalisation. JB Chemicals & Pharmaceuticals Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of JB Chemicals & Pharmaceuticals Limited and ORTIN GLOBAL LIMITED on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, JBCHEPHARM is more favourable on 7 of 10 scored metrics and ORTINGLOBE on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
JBCHEPHARM is the larger company
₹38,731 Cr vs ₹12 Cr
EPS
JBCHEPHARM has higher earnings per share
₹44.49 vs ₹-1.13
Dividend Yield
JBCHEPHARM has a higher dividend yield
1.19% vs 0%
Revenue Growth (TTM YoY)
JBCHEPHARM has faster revenue growth
-4.8% vs -76.86%
EPS Growth (TTM YoY)
ORTINGLOBE has faster EPS growth
0% vs -31%
Qtr Sales Growth
ORTINGLOBE has stronger quarterly sales growth
0% vs -4.77%
Qtr Profit Growth
ORTINGLOBE has stronger quarterly profit growth
0% vs -17%
ROE
JBCHEPHARM has a higher ROE
18.9% vs -59.85%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricJBCHEPHARMORTINGLOBE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricJBCHEPHARMORTINGLOBE
Live Price₹2,408.9₹18.02
Day Change-3.87%0.5%
Volume47.79 L48,801
52-Week High₹2,525.5₹21.3
52-Week Low₹1,638.5₹11
Distance from 52W High-4.62%-15.4%

Valuation

MetricJBCHEPHARMORTINGLOBE
Market Cap₹38,731 Cr₹12 Cr
P/E Ratio54.59x
P/B Ratio9.31x
EPS₹44.49₹-1.13
Book Value₹259.05₹2.43
Dividend Yield1.19%0%

Growth

MetricJBCHEPHARMORTINGLOBE
Revenue Growth (TTM YoY)-4.8%-76.86%
EPS Growth (TTM YoY)-31%0%
Qtr Sales Growth-4.77%0%
Qtr Profit Growth-17%0%

Profitability & Leverage

MetricJBCHEPHARMORTINGLOBE
ROE18.9%-59.85%
ROCE25.4%0%
Net Margin17.1%-529.87%
Operating Margin26.7%
Debt to Equity0x0.81x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricJBCHEPHARMORTINGLOBE
Promoter Holding48.8% 48.8 pp1.23%
FII Holding16.33% 1.45 pp1.8% 0.12 pp
DII Holding21.38% 1.98 pp0%
Public Holding13.48% 0.74 pp96.96% 0.13 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: JB Chemicals & Pharmaceuticals Limited and ORTIN GLOBAL LIMITED.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.